MTOR and Alzheimer disease: The beneficial effects on mTOR signaling may be related to simufilam’s mechanism of action of reversing an altered conformation of FLNA that occurs in AD brain, implied by a shift in isoelectric focusing point (Wang et al., 2017; Wang et al., 2020).